Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT05026866 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 2,996 participants |
| Active Locations | 198 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of March 2, 2026: Clinical trial NCT05026866 is currently active_not_recruiting participants. This clinical trial study for alzheimer's disease is not currently accepting new participants at 198 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05026866 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 198 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05026866 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.